Multi Omics Data Integration to predict the M. tuberculosis Bedaquiline Resistance Phenotype from the Genotype
Study to calibrate antimicrobial susceptibility testing methods and breakpoints against EUCAST ref.standards for bedaquiline, clofazimine, levofloxacin and linezolid. 7 laboratory study with Quality Control strain ATCC 27294 (H37Rv)
Ontwikkeling van nieuwe antimicrobiële middelen tegen tuberculosis die in synergie werken met bedaquiline, cytochrome bc of cytochrome bd inhibitors (RespiriTB)
Ontwikkeling van nieuwe antimicrobiële middelen tegen tuberculosis die in synergie werken met bedaquiline, cytochrome bc of cytochrome bd inhibitors (RespiriTB)
Ontwikkeling van nieuwe antimicrobiële middelen tegen tuberculosis die in synergie werken met bedaquiline, cytochrome bc of cytochrome bd inhibitors (RespiriTB)
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts
Validation of bedaquiline phenotypic drug susceptibility testing methods and breakpoints: a multilaboratory, multicountry study
Linking in vitro intrinsic dissolution rate and thermodynamic solubility with pharmacokinetic profiles of bedaquiline long-acting aqueous microsuspensions in rats
A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant